These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6434264)

  • 21. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
    Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
    Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results?
    Parrish RK
    Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of glaucoma with atenolol eye drops.
    Dhir SP; Sharma PL; Jain IS
    Indian J Ophthalmol; 1981 Oct; 29(3):229-33. PubMed ID: 7346433
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect on diurnal intraocular pressure of the fixed combination of latanoprost 0.005% and timolol 0.5% administered in the evening in glaucoma.
    Polo V; Larrosa JM; Ferreras A; Borque E; Pablo LE; Honrubia FM
    Ann Ophthalmol (Skokie); 2008; 40(3-4):157-62. PubMed ID: 19230353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pilocarpine test and the dynamics of daily intraocular pressure fluctuations in open-angle glaucoma].
    Slavina TM
    Oftalmol Zh; 1981; 36(7):424-5. PubMed ID: 7335262
    [No Abstract]   [Full Text] [Related]  

  • 27. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 28. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma.
    Hotehama Y; Mishima HK; Kitazawa Y; Masuda K
    Jpn J Ophthalmol; 1993; 37(3):270-4. PubMed ID: 8295364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH; Chang FW; Tang IH; Kolin T
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of patients with primary open-angle glaucoma with proxofelin, a combined form of proxodolol].
    Ermakova VN; Malinina SL; Abdulkadyrova MZh; Filippova OM; Maliuta GD
    Vestn Oftalmol; 1999; 115(1):3-5. PubMed ID: 10207309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carteolol in the treatment of open-angle glaucoma].
    Gorgone G; Randazzo S; Spina F
    Ophtalmologie; 1988; 2(5):431-3. PubMed ID: 3244464
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of rheopolyglucin in the combined treatment of patients with open-angle glaucoma].
    Sobko EG
    Oftalmol Zh; 1984; (5):291-3. PubMed ID: 6209600
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pressure-lowering effect of a new cholinesterase inhibitor, Ubretid on glaucoma].
    Sawada A; Hara K; Futa R; Ogata H
    Nihon Ganka Kiyo; 1971 Aug; 22(8):676-82. PubMed ID: 5166066
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of a clinical test of Chlorophthalm].
    Vorob'eva GP; Filatova ZA
    Oftalmol Zh; 1969; 24(2):94-6. PubMed ID: 5807053
    [No Abstract]   [Full Text] [Related]  

  • 37. The case against treating glaucoma.
    Fraser H
    Aust N Z J Ophthalmol; 1995 May; 23(2):159. PubMed ID: 7546695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with local application of Clonidin in glaucoma].
    Edelhauser EM
    Klin Monbl Augenheilkd; 1971 Apr; 158(4):514-7. PubMed ID: 5578932
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of a miotic (arminum) on the child with esotropia].
    Sawamoto Y
    Nihon Ganka Kiyo; 1969 Feb; 20(2):192-7. PubMed ID: 5815607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study on the metabolites of cui-xing-an in rat urine].
    Li H; Ruan JX; Tang BS; Wu LM; Jia JS
    Yao Xue Xue Bao; 1989; 24(4):246-50. PubMed ID: 2816383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.